UK injectables market size 2026: how many new clients are entering the market?

The UK injectables market continues to grow. Botox, dermal fillers, skin boosters, polynucleotides and biostimulatory treatments are no longer only used by a small high income audience. They have become part of a wider consumer market for facial aesthetics, skin quality and subtle maintenance.

The most important question for clinics is no longer only: how big is the market?

The better question is: how many new clients enter the market each year, how many keep returning and what is a new injectable client worth over time?

Injectablesbooking expects the UK injectables market to keep growing in 2026, driven by three main factors:

1. high repeat behaviour among satisfied Botox clients;

2. a steady flow of first time injectable clients;

3. rising demand for skin quality treatments such as skin boosters, Profhilo, polynucleotides and regenerative aesthetics.

How big is the UK injectables market in 2026?

There is no single official figure for the full UK injectables market. The sector is still fragmented and regulation has not fully kept pace with market growth. The UK Parliament noted in 2026 that cosmetic procedures have grown rapidly over the last 20 years, especially non surgical procedures, while regulation has lagged behind.

A useful market benchmark comes from Grand View Research, which estimates that the UK aesthetic injectable market generated USD 493.1 million in revenue in 2025 and could reach USD 1.037 billion by 2033, with expected annual growth of 9.7% from 2026 to 2033.

Based on this, plus UK population size, known Botox volumes and search behaviour, Injectablesbooking estimates the UK market in 2026 as follows:

This means that around 1 in 65 to 85 UK adults may receive an injectable treatment in 2026.

That is already a large market. But it also means the market is still far from saturated. More than 98% of UK adults are not yet active injectable clients.

How many people in the UK have Botox?

Botox remains the strongest repeat treatment in the UK injectables market. UCL reported that a previous estimate put the number of aesthetic botulinum toxin injections in the UK at around 900,000 per year. The same UCL research also found that the proportion of practitioners without a medical background doubled from 12% to nearly 25% between 2023 and 2025.

This matters for two reasons.

First, Botox is a large and repeat driven category. The result is temporary, so satisfied clients often return several times per year.

Second, the UK market has a clear consumer safety challenge. In a growing market, consumers do not always know who is medically qualified and who is not. This makes visibility, trust and clear practitioner information increasingly important.

How many new injectable clients will enter the UK market in 2026?

Injectablesbooking estimates that around 170,000 to 240,000 new injectable clients will enter the UK market in 2026.

These are people booking their first treatment with:

• Botox;

• dermal fillers;

• skin boosters;

• Profhilo;

• polynucleotides;

• biostimulatory injectables;

• collagen stimulating treatments;

• regenerative skin quality treatments.

Most first time clients do not start with a large treatment plan. Many start small. For example, one area of Botox, a subtle lip enhancement, a skin booster or a consultation about tired looking skin.

This is important. The lower the first step feels, the more accessible the market becomes.

What percentage of UK adults are open to injectables?

There is a difference between using injectables, seriously considering injectables and being open to skin improvement treatments.

For the UK in 2026, Injectablesbooking estimates:

The group open to skin quality treatments is likely larger than the group actively searching for Botox or fillers. This is one of the most important market trends.

Many people do not necessarily want a visible change. They want to look fresher, less tired or better rested. Skin boosters, Profhilo and polynucleotides fit that demand better than traditional filler messaging.

How has the UK injectables market changed in recent years?

The UK market has moved through several phases.

First, Botox became mainstream. It is widely recognised, relatively accessible and strongly repeat driven.

Second, dermal fillers grew quickly, especially in lips and facial contouring.

Third, the market started to shift towards more natural results. Consumers became more cautious about overfilled looks and more interested in subtle treatments.

Fourth, skin quality became a major growth area. Treatments such as skin boosters, Profhilo, polynucleotides and regenerative aesthetics now attract consumers who may not want classic fillers.

This does not mean that fillers are disappearing. It means the market is becoming more balanced. The question is shifting from “how can I change my face?” to “how can I maintain my skin and look fresher?”

That is a broader and more sustainable consumer trend.

Why skin boosters and polynucleotides are growing

Skin boosters, Profhilo and polynucleotides are important because they make the injectables market more accessible.

They appeal to people who want:

• better skin quality;

• hydration;

• glow;

• firmer skin;

• fewer fine lines;

• a natural result;

• less tired looking skin;

• gradual improvement instead of a visible change.

This is a different audience from the traditional filler client.

A client who is not ready for dermal filler may still be interested in skin quality. That makes skin boosters and polynucleotides an important entry point for first time injectable clients.

How many injectable clients return every year?

Retention in the injectables market is relatively high. This is especially true for Botox.

Botox is temporary. When clients are satisfied, they often build a regular treatment rhythm. Many return two or three times per year.

A realistic UK estimate for 2026:

This means the UK injectables market is increasingly a maintenance market.

Many clients do not see injectable treatments as a one off purchase. They see them as part of a personal care routine, especially when results are subtle and natural.

How many clients drop out?

Not every client returns every year. But that does not mean they have permanently left the market.

Some clients pause. They may delay treatment because of budget, pregnancy, timing, travel, personal preference or simply because they want a longer interval.

For the UK in 2026, a logical estimate is:

The key point is that high satisfaction creates strong retention. Especially with Botox, people who like the result often continue.

So the market should not be viewed as a market with heavy churn. It is better understood as a market with high repeat behaviour, some temporary pauses and steady first time client growth.

Does the client flow model make sense?

Yes, if the market is split into returning clients, temporary pauses and new clients.

A logical UK model for 2026:

This model does not require a high permanent drop off rate. The market grows because many existing clients return and a large group of new clients enters the category each year.

What is a new injectable client worth?

For clinics, a new injectable client is worth more than the first appointment.

A client may start with one area of Botox. If satisfied, that client may return after a few months. Over time, the same client may add more areas, skin boosters, Profhilo, polynucleotides, fillers or biostimulatory treatments.

A realistic UK client value estimate:

A new injectable client can therefore represent around £1,000 to £2,500 in revenue over several years.

For combination clients, the value can be higher. A client who starts with Botox and later adds skin boosters or polynucleotides may become a long term maintenance client.

Why new clients remain essential for clinics

Even with strong retention, clinics still need new client growth.

Example:

This clinic grows by 9%. But the growth does not come from retention alone. It comes because the number of new clients is higher than the number of clients who pause or leave.

For clinics, the rule is simple:

Retention protects the base. New clients create growth.

Why UK consumers search online before booking injectables

New injectable clients usually start with research. They compare treatments, prices, risks, reviews and practitioners before choosing a clinic.

Common UK searches include:

• How much is Botox in the UK?

• How much is one area of Botox?

• How often do you need Botox?

• What is the difference between Botox and fillers?

• What are skin boosters?

• What is Profhilo?

• What are polynucleotides?

• Are fillers safe?

• Who can inject Botox in the UK?

• How do I find a qualified practitioner?

• Which aesthetic clinic is near me?

This search phase is commercially important. A new client often does not know which clinic to choose. They are still comparing.

The clinic that is visible during this stage has a stronger chance of being considered.

Why qualification and safety matter in the UK

The UK injectables market has grown quickly. But the regulatory environment has been a concern. The UK Parliament noted that regulation has not kept pace with the rise in cosmetic procedures and that inadequately trained individuals have been able to carry out high risk procedures.

In 2025, the UK government announced plans for significant reforms to cosmetic procedures, including botulinum toxin and dermal fillers, with a proposed local authority licensing scheme.

For consumers, this makes safe choice more important.

People want to know:

• who is treating me?

• is the practitioner qualified?

• is the clinic professional?

• are reviews available?

• what treatment is suitable for me?

• what does it cost?

• is there a clinic near me?

This is where comparison platforms become more important. They help consumers move from general interest to a more informed clinic choice.

The role of Injectablesbooking in the UK market

Injectablesbooking helps consumers compare clinics, treatments, prices and experiences.

In a fast growing market, consumers need clarity. They want to find a clinic near them, understand treatment options and choose a practitioner with confidence.

Injectablesbooking expects the UK market in 2026 to be shaped by:

• continued growth in Botox;

• broader interest in skin quality treatments;

• stronger demand for natural results;

• more consumer focus on practitioner qualification;

• more online comparison before booking;

• increasing value of first time injectable clients;

• growing importance of trust and transparency.

The UK market is large, but still underpenetrated. This gives strong growth potential for clinics that are visible when new clients are researching their first treatment.

What does this mean for the UK injectables market in 2026?

Injectablesbooking expects the following market development in 2026:

The strongest commercial opportunity is not only in treating existing clients. It is in reaching the next group of first time clients before they choose a clinic.

Conclusion

The UK injectables market is expected to keep growing in 2026. Injectablesbooking estimates that the market will reach around 1.5 to 1.9 million treatments, 650,000 to 850,000 unique clients and £430 million to £520 million in revenue.

The market is still underpenetrated. Only around 1.2% to 1.5% of UK adults are expected to receive injectable treatments in 2026, while a much larger group is researching or considering them.

The main growth driver is the combination of strong retention and new client inflow. Many satisfied Botox clients keep returning, while skin boosters, Profhilo, polynucleotides and regenerative treatments make the category more accessible for new consumers.

For clinics, a new injectable client is valuable. The first treatment may be modest, but the long term value can reach £1,000 to £2,500 over several years.

For consumers, the key question remains: which clinic is right for me, and which practitioner can I trust?

That is where Injectablesbooking plays a clear role. It helps consumers compare clinics, treatments, prices and experiences, so they can make a more informed choice for an aesthetic clinic in their region.